About Axplora
Axplora is a company based in Lyon (France) founded in 1995 was acquired by BNP Paribas in November 2006. It operates as a Professional Services. Axplora has raised $3.97 million across 2 funding rounds from investors including BNP Paribas, Azulis Capital and Banexi Capital Partenaires. Axplora offers products and services including API Manufacturing, ADC Manufacturing, and HPAPI Manufacturing. Axplora operates in a competitive market with competitors including Diversey, Syngene, Abzena, Patheon and Piramal Group, among others.
- Headquarter Lyon, France
-
Sectors
HealthcareIndustrial Goods & Manufacturing
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Axplora Group Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.97 M (USD)
in 2 rounds
-
Latest Funding Round
$314.81 K (USD), Grant
Feb 01, 2019
-
Investors
BNP Paribas
& 3 more
-
Employee Count
Not available
-
Acquired by
BNP Paribas
(Nov 29, 2006)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Axplora
Axplora offers a comprehensive portfolio of products and services, including API Manufacturing, ADC Manufacturing, and HPAPI Manufacturing.
Active pharmaceutical ingredients are manufactured for global clients.
Antibody-drug conjugates are produced for oncology treatments.
Highly potent APIs are developed for specialized drugs.
Funding Insights of Axplora
Axplora has successfully raised a total of $3.97M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $314.81 thousand completed in February 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Axplora
Axplora has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include BNP Paribas, Azulis Capital and Banexi Capital Partenaires.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity fund focused on health care, food and beverages, consumers, and multiple sectors
|
Locked | Locked | Locked | |
|
Private equity and accelerator investments are directed toward multiple sectors.
|
Locked | Locked | Locked | |
|
Banking & financial service provider
|
Locked | Locked | Locked |
Investor details for Axplora
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Axplora
Investment portfolio details for Axplora
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Axplora
Detailed financials for Axplora
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Axplora Comparisons
Peer comparison for Axplora
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Axplora
Axplora operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Diversey, Syngene, Abzena, Patheon and Piramal Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Water treatment and hygiene solutions are provided for various industries.
|
|
| Locked | Locked | Locked |
Provider of contract research and manufacturing services for both small molecules and biologics
|
|
| Locked | Locked | Locked |
Provider of antibody discovery, cell line development, and bio analytics services
|
|
| Locked | Locked | Locked |
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry
|
|
| Locked | Locked | Locked |
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
|
|
| Locked | Locked | Locked |
Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering
|
Detailed competitors of Axplora
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Axplora
Complete news archive for Axplora
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Axplora
Axplora was founded in 1995 and raised its 1st funding round 17 years after it was founded.
Axplora is headquartered in Lyon, France. It is registered at Lyon, Auvergne-rhone-alpes, France.
Pierre Lunel is the current CEO of Axplora.
Axplora is a funded company, having raised a total of $3.97M across 2 funding rounds to date.
Axplora is engaged in the development and manufacturing of active pharmaceutical ingredients (APIs) and advanced therapies like antibody-drug conjugates (ADCs) for the pharmaceutical industry. Operating across Europe, India, and the US, the company serves over 900 customers and benefits millions of patients worldwide. Specialized services include API development, HPAPI manufacturing, and technologies such as chromatography and flow chemistry. Sectors covered include oncology and metabolic disorders, with a focus on sustainable and technologically advanced solutions.
Axplora's top competitors include Abzena, Syngene and Grand River Aseptic Manufacturing.
Axplora offers API Manufacturing, ADC Manufacturing, and HPAPI Manufacturing.
Axplora has 4 investors. Key investors include BNP Paribas, Azulis Capital, Banexi Capital Partenaires, and Rivean Capital.